Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment

Journal of Rheumatology

Volumn 41, Issue 6, 2014, Pages 1112-1117

  Hmamouchi, Ihsane ^a,b,c   Roux, Christian ^a,b   Paternotte, Simon ^a,b   Kolta, Sami ^a,b   Dougados, Maxime ^a,b   Briot, Karine ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Epidemiology and Biostatistics Unit   (France)

^c MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

Abdominal adiposity; Anti tumor necrosis factor ; Spondyloarthritis visceral adipose tissue; Subcutaneous adipose tissue

Indexed keywords

ETANERCEPT; INFLIXIMAB; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ABDOMINAL OBESITY; ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; FOLLOW UP; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SPONDYLARTHRITIS; SPONDYLITIS; TREATMENT DURATION; WAIST CIRCUMFERENCE; WEIGHT GAIN; ABDOMINAL FAT; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; MIDDLE AGED; OBESITY; RADIOGRAPHY; RISK FACTOR; TREATMENT OUTCOME;

ABDOMINAL FAT; ADIPOSITY; ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; BODY MASS INDEX; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; SPONDYLARTHRITIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE;

EID: 84901711538     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.131150     Document Type: Article

References (33)

1. Dougados M, Baeten D. Spondyloarthritis. Lancet 2011;377:2127-37.
2. Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, et al. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 2000;43:1346-52. (Pubitemid 30416320)
3. Briot K, Garnero P, Le Henanff A, Dougados M, Roux C. Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor a treatment. Ann Rheum Dis 2005;64:1137-40. (Pubitemid 41113346)
4. Briot K, Gossec L, Kolta S, Dougados M, Roux C. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. J Rheumatol 2008;35:855-61. (Pubitemid 351747128)
5. Phillips GB, Jing T, Heymsfield SB. Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 2003;2:784-90. (Pubitemid 36896315)
6. Shuman WP, Morris LL, Leonetti DL, Wahl PW, Moceri VM, Moss AA, et al. Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 1986;21:483-7. (Pubitemid 16036440)
7. Kvist H, Chowdhury B, Grangård U, Tylén U, Sjöström L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988;48:1351-61. (Pubitemid 19008565)
8. Ball SD, Swan PD. Accuracy of estimating intraabdominal fat in obese women. J Exerc Physiol Online 2003;6:1-7. (Pubitemid 40706054)
9. Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 2012;85:1-10.
10. Micklesfield LK, Goedecke JH, Punyanitya M, Wilson KE, Kelly TL. Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat. Obesity 2012;20:1109-14.
11. Taylor AE, Kuper H, Varma RD, Wells JC, Bell JD, V Radhakrishna K, et al. Validation of dual energy X-ray absorptiometry measures of abdominal fat by comparison with magnetic resonance imaging in an Indian population. PLoS One 2012;7:e51042.
12. Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Shapiro MD, et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity 2012;20:1313-8.
13. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
14. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8. (Pubitemid 14134775)
15. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
16. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: WHO; 2000;894:i-xii, 1-253.
17. Després JP, Moorjani S, Ferland M, Tremblay A, Lupien PJ, Nadeau A, et al. Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat. Arteriosclerosis 1989;9:203-10. (Pubitemid 19092103)
18. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity 2006;14:336-41. (Pubitemid 46214766)
19. Bray G, Bouchard C, James W. Handbook of obesity. New York: Dekker; 1998:1012.
20. Després JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001;322:716-20. (Pubitemid 32238779)
21. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8. (Pubitemid 24096208)
22. Lemieux I, Poirier P, Bergeron J, Alméras N, Lamarche B, Cantin B, et al. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol 2007;23:23B-31B. (Pubitemid 47629137)
23. Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-62. (Pubitemid 14212633)
24. Poirier P, Després JP. Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil 2003;23:161-9. (Pubitemid 36666838)
25. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007;17:319-26. (Pubitemid 46551691)
26. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48. (Pubitemid 47016245)
27. Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clinical Rheum 2007;26:710-4. (Pubitemid 46554077)
28. Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Shapiro MD, et al. Dual-energy x-ray absorptiometry for quantification of visceral fat. Obesity 2012;20:1313-8.
29. Bodnar RJ, Pasternak GW, Mann PE, Paul D, Warren R, Donner DB. Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat. Cancer Res 1989;49:6280-4. (Pubitemid 20000923)
30. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001;60:349-56. (Pubitemid 32772450)
31. Garcia-Martinez C, Lopez-Soriano FJ, Argiles JM. Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem 1993;125:11-8. (Pubitemid 23298785)
32. Franchimont D, Roland S, Gustot T, Quertinmont E, Toubouti Y, Gervy MC, et al. Impact of infliximab on serum leptin levels in patients with Crohn's disease. J Clin Endocrinol Metab 2005;90:3510-6. (Pubitemid 41014321)
33. Durcan L, Wilson F, Conway R, Cunnane G, O'Shea FD. Increased body mass index in ankylosing spondylitis is associated with greater burden of symptoms and poor perceptions of the benefits of exercise. J Rheumatol 2012;39:2310-4.